| 08/07/2026 4:28 PM | MORGAN STANLEY (895421) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 08/07/2026 4:32 PM | MORGAN STANLEY (895421) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 08/07/2026 10:07 AM | FMR LLC (315066) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 08/06/2026 9:48 AM | FMR LLC (315066) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 07/31/2026 9:47 AM | VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 07/30/2026 10:18 AM | BlackRock, Inc. (2012383) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 07/20/2026 3:40 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:22 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:25 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:26 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:28 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
Get the Latest News and Ratings for XOMA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for XOMA Royalty and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/20/2026 3:29 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:29 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:30 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:31 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:34 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:35 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:35 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:36 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:16 PM | XOMA Royalty (791908) Filer | Form POS AM | |
| 07/20/2026 3:19 PM | XOMA Royalty (791908) Filer | Form S-8 POS | |
| 07/16/2026 4:00 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13D/A | |
| 07/16/2026 4:02 PM | BIOTECHNOLOGY VALUE FUND II LP (1102444) Reporting BIOTECHNOLOGY VALUE FUND L P (918923) Reporting Biotechnology Value Trading Fund OS LP (1660683) Reporting BVF GP HOLDINGS LLC (1803809) Reporting BVF I GP LLC (1803805) Reporting BVF II GP LLC (1803806) Reporting BVF INC/IL (1056807) Reporting BVF PARTNERS L P/IL (1055947) Reporting BVF Partners OS Ltd. (1660684) Reporting LAMPERT MARK N (1233840) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/16/2026 7:31 AM | Nasdaq Stock Market LLC (1354457) Filed by XOMA Royalty (791908) Subject | Form 25-NSE | |
| 07/15/2026 9:39 AM | Nasdaq Stock Market LLC (1354457) Filed by XOMA Royalty (791908) Subject | Form 25-NSE | |
| 07/14/2026 8:45 PM | Franklin Heather L (1436658) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | PERRY MATTHEW D (1454337) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Sitko Bradley (1959809) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Hernday Natasha (1780547) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Hughes Owen (1575933) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Kosacz Barbara (1763316) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | LIMBER JOSEPH M (1216023) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Montano Maricel Perea (2076299) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:10 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2026 4:22 PM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2026 4:24 PM | XOMA Royalty (791908) Filer | Form DEFA14A | |
| 06/10/2026 4:19 PM | XOMA Royalty (791908) Filer | Form DEFM14A | |
| 05/26/2026 5:07 PM | Kosacz Barbara (1763316) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:07 PM | Franklin Heather L (1436658) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Washington just doubled the size of this company (Ad) On May 21, 2026, a federal bank's board voted unanimously to approve nearly $3 billion in financing for a small American mining company, more than the entire business is worth on the open market.
Congress received 25 days' notice and raised zero objections. Final papers are expected in the second half of 2026, after which the company shifts from speculative developer to federally backed strategic asset. It still trades at about 1/50th the size of Newmont. See the name, ticker, and paperwork before the signature. |
| 05/26/2026 5:08 PM | PERRY MATTHEW D (1454337) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | Hernday Natasha (1780547) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | LIMBER JOSEPH M (1216023) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 10:28 AM | XOMA Royalty (791908) Subject | Form 425 | |
| 05/22/2026 5:01 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 4:26 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13D/A | |
| 05/18/2026 4:29 PM | BIOTECHNOLOGY VALUE FUND II LP (1102444) Reporting BIOTECHNOLOGY VALUE FUND L P (918923) Reporting Biotechnology Value Trading Fund OS LP (1660683) Reporting BVF GP HOLDINGS LLC (1803809) Reporting BVF I GP LLC (1803805) Reporting BVF II GP LLC (1803806) Reporting BVF INC/IL (1056807) Reporting BVF PARTNERS L P/IL (1055947) Reporting BVF Partners OS Ltd. (1660684) Reporting LAMPERT MARK N (1233840) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 8:11 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 8:13 AM | XOMA Royalty (791908) Filer | Form DEFA14A | |
| 05/15/2026 8:03 AM | Woodline Partners LP (1784547) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G | |
| 05/12/2026 3:06 PM | XOMA Royalty (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/01/2026 8:15 PM | LIGAND PHARMACEUTICALS INC (886163) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13D | |
| 04/30/2026 1:38 PM | VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G | |
| 04/29/2026 4:43 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13D/A | |
| 04/27/2026 6:37 PM | LIGAND PHARMACEUTICALS INC (886163) Filer XOMA Royalty (791908) Filer | Form DEFA14A | |
| 04/27/2026 3:12 PM | BlackRock, Inc. (2012383) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G | |
| 04/27/2026 3:01 PM | XOMA Royalty (791908) Filer | Form 8-K/A | |
| 04/27/2026 7:16 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/27/2026 7:19 AM | XOMA Royalty (791908) Filer | Form DEFA14A | |
| 04/22/2026 3:30 PM | Sitko Bradley (1959809) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Hughes Owen (1575933) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Montano Maricel Perea (2076299) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:13 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 3:30 PM | LIMBER JOSEPH M (1216023) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 4:34 PM | XOMA Royalty (791908) Filer | Form DEFA14A | |
| 03/30/2026 4:35 PM | XOMA Royalty (791908) Filer | Form ARS | |
| 03/27/2026 1:14 PM | VANGUARD GROUP INC (102909) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 03/26/2026 3:30 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 5:45 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/17/2026 3:38 PM | Hughes Owen (1575933) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Montano Maricel Perea (2076299) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Sitko Bradley (1959809) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 9:05 AM | FMR LLC (315066) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 03/02/2026 5:04 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 1:36 PM | MORGAN STANLEY (895421) Filed by XOMA Royalty (791908) Subject | Form SCHEDULE 13G/A | |
| 02/09/2026 3:19 PM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/30/2026 4:14 PM | Generation Bio Co. (1733294) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 01/15/2026 3:25 PM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 3:30 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 01/14/2026 3:35 PM | Trigilio Jeffrey (1838671) Reporting XOMA Royalty (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 6:58 AM | Generation Bio Co. (1733294) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 01/12/2026 6:00 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:05 PM | Generation Bio Co. (1733294) Subject XOMA Royalty (791908) Filed by | Form SC TO-T | |
| 12/15/2025 7:36 PM | Generation Bio Co. (1733294) Subject XOMA Royalty (791908) Filed by | Form SC TO-C | |
| 12/05/2025 8:15 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/21/2025 6:50 AM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 11/21/2025 7:03 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
What Goldman just admitted they got wrong about gold (Ad) Goldman Sachs just revised its central bank gold buying estimate by more than 500%, raising its year-end target to $5,400/oz. Bank of America, JPMorgan, and Wells Fargo see prices reaching $6,000 to $6,300/oz.
The revised model shows central banks buying at nearly $7 billion per month, with expectations of $8 to $9 billion monthly through 2026, close to $100 billion for the year. Get the free Wealth Protection Playbook and see the details |
| 11/13/2025 6:16 AM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 11/12/2025 6:46 AM | XOMA Royalty (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2025 6:46 AM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 11:22 AM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 10/03/2025 4:24 PM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/03/2025 4:00 PM | XOMA Royalty (791908) Filer | Form 424B5 | |
| 10/03/2025 4:03 PM | XOMA Royalty (791908) Filer | Form 424B5 | |
| 10/02/2025 3:35 PM | LAVA Therapeutics NV (1840748) Subject XOMA Royalty (791908) Filed by | Form SC TO-T/A | |
| 09/26/2025 4:29 PM | XOMA Royalty (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |